Related Experiment Video
Updated: Jun 8, 2026
15:18
Making MR Imaging Child's Play - Pediatric Neuroimaging Protocol, Guidelines and Procedure
Published on: July 30, 2009
[Medical research in children: should the rules be eased?]
1Leids Universitair Medisch Centrum, afd. Kindergeneeskunde, Leiden, the Netherlands. a.e.westra@lumc.nl
Nederlands Tijdschrift Voor Geneeskunde
|September 23, 2010
Summary
Non-therapeutic research in children is vital for advancing pediatric care but faces strict limits. This paper examines recommendations to revise regulations, arguing for minimal risks and burdens in all child research lacking direct benefit.
Area of Science:
- Pediatric research ethics
- Clinical trial regulations
- Child health research
Context:
- Current Dutch Medical Research Involving Human Subjects Act (WMO) strictly limits non-therapeutic research in children.
- Non-therapeutic research, not directly benefiting child participants, is essential for pediatric care improvement.
- A Dutch expert committee proposed revising WMO regulations regarding child research.
Purpose:
- To discuss the recommendations of the 'committee Doek' regarding the WMO.
- To analyze the proposed shift away from the therapeutic/non-therapeutic research distinction.
- To advocate for maintaining minimal risk and burden standards in pediatric research.
Summary:
- The 'committee Doek' suggests moving away from the therapeutic/non-therapeutic research distinction for children.
- Recommendations include maintaining strict risk and burden limits only for observational studies in children under 12.
- The paper argues for a principle of minimizing risks and burdens in all research lacking direct benefit to child subjects.
Impact:
- Potential revision of Dutch regulations governing research involving children.
- Facilitating essential pediatric research while upholding ethical standards.
- Ensuring the protection of children participating in clinical studies and medical research.
Related Concept Videos
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
01:56Ethics in Research
Today, scientists agree that good research is ethical in nature and is guided by a basic respect for human dignity and safety. However, this has not always been the case. Modern researchers must demonstrate that the research they perform is ethically sound.
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
01:15Bioavailability Study Design: Healthy Subjects Versus Patients
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...